Cantrixil: Advancing a Molecule’s Career with a Cyclodextrin Carrier
The success story of Cantrixil, a potent anti-cancer drug candidate, has been followed on our blog for years, and now
Tag: cancer
Methyl BCD-based supramolecular polyrotaxane as theranostic in anticancer immunotherapy
Despite the tremendous therapeutic promise of activating stimulators of interferon genes (STING) enable to prime robust de novo T-cell responses,
An Updated Overview of Cyclodextrin-Based Drug Delivery Systems for Cancer Therapy
Cancer denotes a group of more than a hundred types of diseases characterized by the malignant form of abnormal tissue
HPBCD solubilized drug candidate is effective to treat prostate tumor – as published in Nature
Scientists at the University of Michigan have described a key nexus that several cancer-promoting genes depend on to drive prostate
KAZIA LICENSES CANTRIXIL TO OASMIA
Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, announced that it has entered into an exclusive worldwide license agreement with
In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography
The cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) pathway plays an important role in tumor development and formation of metastases. It was earlier
Cyclodextrins in doll-inspired nanostructures for cancer therapy
A young researcher working at the Centre de Recherche en Automatique de Nancy, Centre National de la Recherche Scientifique has recently
NO-delivering fluorescent beta-cyclodextrin polymer
A novel water-soluble β-cyclodextrin branched polymer covalently integrating a fluorescein moiety and a nitric oxide (NO) photodonor within its macromolecular
Cyclodextrin News Year in Review 2018
The CDNews blog was created in July and after a short period of trial it started in September. During this
A patent application for potential medical use of CD-based (poly)catenanes
Researchers from Kumamoto University (Hidetoshi Arima, Keiichi Motoyama, Taishi Higashi) filed an international patent application on a novel synthesis of